🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Financials Sector SEC Filings — July 20, 2026

The three filings from the S&P 500 Financials sector reveal a mixed picture of capital management and insider sentiment. Intercontinental Exchange (ICE) and Robinhood Ventures Fund I both show significant insider selling, with ICE's NYSE Group President executing a large sale under a 10b5-1 plan, while Robinhood's parent company also reduced its stake, signaling potential caution at the top. In contrast, Goldman Sachs is proactively managing its capital structure with a preferred stock offering to refinance higher-cost debt, a neutral but strategically sound move. Period-over-period comparisons are limited in these filings, but the insider activity pattern suggests a bearish tilt among executives in exchange and fintech subsectors. The key themes are insider de-risking and opportunistic capital optimization, with Goldman's refinancing offering a potential yield opportunity for income-focused investors.

2 high priority 1 medium 3 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 20, 2026

The three filings from the S&P 500 Energy sector reveal a bifurcated insider activity pattern: while Kinder Morgan insiders are executing routine tax-related share withholdings under 10b5-1 plans, a 10% owner at Texas Pacific Land Corp made a token purchase, signaling long-term confidence despite a small transaction size. No period-over-period financial trends, forward-looking guidance, or capital allocation changes were reported in these filings, limiting the depth of portfolio-level trend analysis. The insider transactions at Kinder Morgan are non-discretionary and do not indicate management concern, while the Texas Pacific Land buy is a positive but negligible signal. The lack of operational metrics, M&A, or guidance updates across all three filings suggests a quiet period for these energy constituents, with no immediate catalysts or red flags. The key takeaway is that the sector is in a steady state with no material shifts in management sentiment or corporate strategy from these disclosures.

3 high priority 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — July 20, 2026

The sole filing in this Consumer Staples digest comes from Hershey Co, revealing a notable insider sale by the 10% owner, Hershey Trust Co, which sold approximately $1.17 million in stock under a 10b5-1 plan. While the sale is pre-planned and not discretionary, the negative sentiment and materiality score of 5/10 warrant attention, especially given the trust's outsized influence as a controlling shareholder. No period-over-period comparisons, forward-looking guidance, or capital allocation data were available in this filing, limiting the ability to assess broader operational trends. The key takeaway is a potential signal of reduced conviction from a major stakeholder, though the 10b5-1 structure mitigates immediate alarm. Investors should monitor for any subsequent filings or earnings calls that might clarify the trust's long-term intentions.

1 high priority 1 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 20, 2026

The 15 filings from the S&P 500 Industrials stream reveal a sector bifurcating between strong top-line growth and margin pressures. FedEx's 10-K shows a 8% revenue increase to $94.7B, but a 10 bps consolidated margin decline masks a severe 970 bps contraction in its Freight segment, signaling structural headwinds in ground freight. Honeywell and Honeywell Aerospace filings show routine insider stock-for-tax transactions by top executives, including CEO Vimal Kapur and Aerospace CEO James Currier, indicating no unusual conviction signals. Uber Technologies filings also show routine insider RSU conversions and tax withholding by the CFO and other officers, with no open-market buying or selling. The dominant theme is the absence of bullish insider activity and the presence of significant operational stress at FedEx Freight, which should be a key watch item for the broader transportation and logistics sub-sector.

15 high priority 15 total filings
· daily

Insider Trading Pulse — July 20, 2026

Today's insider trading pulse reveals a bifurcated market with significant insider selling by multiple C-suite executives at Sea Ltd, Incyte Corp, and MapLight Therapeutics, contrasting with notable insider buying at Flora Growth Corp and 17 Education & Technology Group. The most material insider sale came from Toyota Motor Corp's Vice Chairman ($1.58M), while the largest buy was Flora Growth's Executive Chairman ($3.48M). A striking pattern emerges with Director Mahai Chris LaVictoire making coordinated purchases across four abrdn healthcare funds, signaling conviction in the healthcare sector. The day is dominated by neutral award filings (stock options, RSUs) which represent routine compensation, but the concentrated selling by CFOs and COOs at Sea Ltd and MapLight warrants close attention. Period-over-period trends from the enriched data show no major revenue or margin shifts reported in these filings, as the focus remains on transaction-level insider activity. The most critical development is the coordinated insider selling at Sea Ltd across three top executives totaling over $1.28M, all under 10b5-1 plans, which may indicate a pre-planned diversification strategy rather than a negative signal.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 20, 2026

The 12 filings from Dow 30 constituents are dominated by routine insider transactions at Honeywell and Disney, where executives exercised and withheld shares for taxes—a neutral signal of standard equity compensation, not conviction selling. The sole corporate action is Goldman Sachs' launch of a preferred stock offering to refinance higher-cost Series U preferreds, a capital management move that modestly improves its cost of capital. No period-over-period trends, forward guidance, or capital allocation changes were disclosed in these filings, limiting the ability to extract portfolio-level growth or margin trends. The key takeaway is the absence of material strategic signals: no insider buying, no guidance changes, and no dividend or buyback updates. The Goldman Sachs offering is the only actionable event, signaling a refinancing opportunity that could save ~$15M annually on preferred dividends. Overall, the digest reflects a quiet period for Dow 30 blue chips, with no bullish or bearish catalysts emerging from this batch.

11 high priority 1 medium 12 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 20, 2026

The July 20, 2026 corporate distress landscape is dominated by acute delisting and bankruptcy events, with three of four filings representing severe liquidity or compliance failures. Smart Powerr Corp. (CREG) faces imminent Nasdaq suspension (July 21) and a move to OTCQB, while Sangamo Therapeutics (SGMOQ) has entered Chapter 11 with a forced asset sale deadline of August 4. SES AI Corp (SES) received a NYSE non-compliance notice but has a six-month cure period, offering a more manageable timeline. In contrast, TEN Holdings (XHLD) has temporarily resolved its Nasdaq equity deficiency via a $6.6M offering, though monitoring continues. The period-over-period data reveals no revenue growth or margin trends across these filings, as all are pre-revenue or distressed. Insider activity is absent, and no capital allocation actions (dividends, buybacks) are reported. The overarching theme is a cascade of small-cap biotech and energy companies failing to meet exchange listing standards, with Sangamo's bankruptcy representing the most terminal outcome. The market implication is heightened risk for micro-cap stocks with low liquidity and reliance on equity raises for compliance.

4 high priority 4 total filings
· daily

US SEC Filings Daily Market Digest — July 20, 2026

Today's digest (July 20, 2026) is eventful, dominated by a major SPAC merger filing (DRC Medicine/Ribbon Acquisition), a high-profile IPO (Jersey Mike's Subs), a significant corporate restructuring (Flex Ltd. spin-off), and a mining sector consolidation (Gold Resource Corp/Goldgroup). Enriched period data reveals a clear divergence: consumer-facing names like Domino's Pizza are showing pronounced same-store sales stagnation (US +0.1%, Int'l -0.1%), while assets like Investar Holding Corp demonstrate mixed results with a strong YoY earnings recovery (+98% YoY, albeit down QoQ). A notable cluster of auditor changes and financial restatements create risk flags across micro-cap names like Adapti and Spectral Capital. Insider activity is sparse, with the most material being a newly filed controlling 75% stake in Margaree Acquisition Corp. Capital allocation trends are mixed, with a healthy IPO pipeline and SPAC activity alongside a concerning lack of revenue generation at Alternus Clean Energy. The 13F filings paint a broadly neutral picture, showing large institutional portfolios heavily tilted towards fixed-income ETFs and mega-cap tech, suggesting a 'risk-off but with concentrated bets' stance. Key catalysts to watch include the DRC Medicine SPAC shareholder vote, Jersey Mike's pricing, and the continued MHRA decision for Northwest Biotherapeutics.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 20, 2026

The sole filing in this digest, from Centene Corp, involves a routine insider equity award to Director Tyler Lauren M, carrying a neutral sentiment and moderate materiality (6/10). This transaction is a standard compensation grant of 3,155 common stock shares, not a market purchase or sale, and therefore does not signal a change in management conviction. With no other filings in the period, there are no portfolio-level trends, period-over-period comparisons, or sector-wide patterns to synthesize. The digest is limited to this single, non-actionable event, providing no bullish or bearish catalysts for the S&P 500 Healthcare sector.

1 high priority 1 total filings
· daily

US Earnings Financial Results SEC Filings — July 20, 2026

The 13 filings reveal a bifurcated market: established operators like Domino's Pizza and MillerKnoll show steady but slowing growth, while a cluster of micro-cap companies (Alternus, Bakhu, Hestia, ANVI Global) continue to burn cash with no revenue or worsening deficits. FedEx's mixed results highlight a tale of two segments—strong parcel demand vs. a sharp freight downturn. A notable theme is the emergence of digital asset exposure in small caps: Pineapple Financial's balance sheet now holds $49.4M in digital assets, a transformative but high-risk allocation. Period-over-period trends show revenue growth at Park Aerospace (+18.9% YoY) and AB International (+103% YoY), but these are offset by margin compression at FedEx Freight (-970 bps) and MillerKnoll's declining organic orders. Insider activity is sparse across filings, limiting conviction signals, but capital allocation patterns reveal aggressive financing (PIPEs, preferred shares) among cash-strapped firms. The most critical development is FedEx's $738M spin-off costs, signaling a major restructuring that could unlock value or add execution risk.

13 high priority 13 total filings
· daily

US Executive Compensation Proxy SEC Filings — July 20, 2026

This batch of 9 proxy filings reveals a market bifurcated between distressed SPACs and micro-cap companies facing existential threats, and a smaller cohort pursuing operational efficiencies. The most critical development is Origin Materials' unanimous board decision to dissolve and liquidate, a stark admission of failed strategy that sets a negative precedent for pre-revenue industrial tech. SPACs FutureTech II and Inflection Point V are both scrambling for extensions, with the former trading on OTC Markets and facing potential CFIUS scrutiny, highlighting systemic risk in the blank-check sector. Conversely, Sound Shore Fund and Bow River Capital are pursuing structural reorganizations to gain cost and compliance efficiencies, signaling a 'flight to quality' in fund management. Insider activity is notably absent across most filings, but CEO Steven Rossi's 51% voting control at Worksport is a significant governance red flag. The forward-looking catalyst calendar is dense with shareholder meetings in late August and early September 2026, creating a binary event window for several of these securities.

9 high priority 9 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 20, 2026

The IPO pipeline on July 20, 2026, is dominated by a mix of early-stage, high-risk micro-cap offerings and a transformative biotech merger, with no clear sector theme. The most material development is Standard BioTools' all-stock merger with Treeline Biosciences, a $2.5 billion deal that will result in a combined entity with a new name and contingent value rights, signaling a major strategic pivot. However, the pipeline is heavily weighted toward speculative, development-stage companies (RZ Wellness, Londonla Inc.) with no revenue, going-concern risks, and self-underwritten offerings, indicating a surge in low-quality filings. Period-over-period comparisons are largely absent as most filers have no prior operating history, but the lack of insider buying and the prevalence of going-concern warnings create a bearish undercurrent. The Grayscale Worldcoin ETF filing represents a niche but notable push into crypto-based ETFs, while the TCGX Acquisition Corp. SPAC offers a more traditional blank-check structure. Overall, the pipeline shows a bifurcation: one high-quality, high-value merger and a cluster of speculative, high-risk micro-cap IPOs that demand extreme caution.

7 high priority 7 total filings
· daily

US SEC Trading Suspension Halt Orders — July 20, 2026

The July 20, 2026, trading suspension landscape is dominated by a cluster of small-cap companies facing Nasdaq/NYSE non-compliance, with two new filings (Smart Powerr Corp. and SES AI Corp) adding to the existing TEN Holdings situation. The most critical development is Smart Powerr Corp.'s imminent delisting and suspension on July 21, 2026, after failing to appeal a bid price deficiency, which will force a move to the OTCQB market with severe liquidity implications. SES AI Corp has received a similar NYSE notice but has a six-month cure period, providing a more manageable timeline, while TEN Holdings has temporarily resolved its equity deficiency through a $6.6M offering but remains under Nasdaq monitoring. The common thread is a liquidity crisis among micro-cap issuers, with all three companies showing deteriorating financial metrics and no insider buying to signal management confidence. The aggregate data reveals a pattern of regulatory fatigue, where companies exhaust compliance plans and appeal processes before facing final suspension orders.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — July 20, 2026

This digest of 21 SEC filings reveals a wave of executive and director changes across US-listed companies, with a notable concentration in the financial sector (banks and specialty finance) and life sciences. The period-over-period data from Investar Holding Corp shows a mixed earnings picture: net income declined 22.6% QoQ but surged 97.8% YoY, while net interest margin improved 8 bps. Forward-looking data from MultiSensor AI Holdings and USA Rare Earth provides key catalyst calendars, with the latter's CEO transition tied to a transformative merger. Insider activity is limited, but the appointment of a Galaxy Digital executive to Forward Industries' board signals deepening strategic ties. Capital allocation trends are sparse, though Chain Bridge Bancorp's enhanced incentive plans and Investar's operational conversion point to retention and integration focus. The most critical development is USA Rare Earth's leadership transition and pending merger, which carries high materiality and execution risk. Overall, the filings suggest a period of strategic repositioning and leadership refresh, particularly in banking and emerging technology sectors, with limited immediate financial impact from most changes.

21 high priority 21 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — July 20, 2026

The single filing in this stream, Sangamo Therapeutics' 8-K, confirms a definitive Chapter 11 bankruptcy and forced asset sale, marking a terminal event for the biotech. The company has no period-over-period comparisons, insider activity, or forward guidance, as the filing focuses solely on court-approved bidding procedures. The key development is the August 4, 2026 bid deadline and potential August 10 auction, creating a binary catalyst for distressed debt and asset buyers. The Nasdaq delisting and OTC trading underscore the collapse in equity value, with no recovery path for common shareholders. This filing represents a pure distressed asset play with no operational turnaround narrative, making it a high-risk, high-reward opportunity for specialized investors.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 20, 2026

The July 20, 2026, boardroom changes stream reveals a high volume of leadership transitions across 21 filings, with a notable concentration of CFO appointments and director additions. The most critical development is the leadership transition at USA Rare Earth, where CEO Barbara Humpton will retire effective October 1, 2026, coinciding with the anticipated closing of the Serra Verde combination—a high-stakes event with a materiality score of 9/10. The banking sector shows a pattern of strategic hires, with Hanover Bancorp appointing a new President with over 35 years of experience and Republic Bancorp experiencing a divisional president departure. Insider activity is limited, with no significant insider buying or selling detected across the filings. Forward-looking data is sparse, but MultiSensor AI Holdings' PSUs tied to 2029 revenue targets ($31.5M threshold, $45.0M target) provide a long-term performance benchmark. Capital allocation insights are minimal, though Forward Industries' deepening ties with Galaxy Digital through board appointments and existing agreements warrant monitoring. The overall sentiment is predominantly neutral, with only one positive sentiment (Lightwave Logic) and one negative sentiment (URSB Bancorp director departure).

21 high priority 21 total filings
· daily

USA Insider Trading Pulse — July 20, 2026

The July 20, 2026 insider trading pulse reveals a market characterized by cautious insider selling at elevated levels, particularly within the biotech and tech sectors, while notable insider buying is concentrated in small-cap and distressed names, signaling potential value opportunities. A significant cluster of 10b5-1 plan sales from multiple C-suite executives at Sea Ltd, MapLight Therapeutics, and Nexxen International suggests pre-planned, tax-related, or liquidity-driven selling rather than outright bearish sentiment, though the volume warrants monitoring. Conversely, a strong bullish signal emerges from Flora Growth Corp., where the Executive Chairman deployed $3.48M in a massive open-market purchase, and from a director at abrdn Healthcare funds who made coordinated, equal-value purchases across four closed-end funds, indicating a targeted value play. The day is dominated by neutral, non-discretionary events such as equity awards and tax-withholding sales, which do not reflect management conviction. Key themes include a concentration of insider selling in biotech (Incyte, MoonLake, MapLight), a pattern of insider buying in deeply undervalued small-caps (Flora Growth, 17 Education, SOLAI), and a notable lack of forward-looking guidance or capital allocation changes in the filings, limiting catalyst visibility. The most actionable intelligence lies in the contrast between the high-conviction buying in select micro-caps and the systematic, 10b5-1-driven selling in growth and biotech names, suggesting a rotation from momentum to deep value.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — July 20, 2026

The July 20, 2026 M&A landscape is dominated by SPAC turbulence and precious metals consolidation. Two SPACs (Compass Digital, DT Cloud Star) face imminent dissolution or delisting due to failed business combinations and regulatory non-compliance, while Drugs Made In America navigates a complex three-party merger with massive shareholder redemptions. In precious metals, Gold Resource Corp's acquisition by Goldgroup Mining creates a combined entity with diversified Mexican and US assets, signaling sector consolidation. Aterian's asset sale and CVR issuance represents a distressed restructuring, while Aptorum Group's merger with DiamiR and reverse split aims for a Nasdaq fresh start. Mawson Infrastructure's JV acquisition of a Texas power site for AI/HPC use highlights the growing convergence of energy and digital infrastructure. Insider activity is sparse but notable, with Oxley Bridge's board resignation and Compass Digital's unanimous shareholder vote for wind-up indicating management alignment with dissolution. The period-over-period data reveals no revenue or margin trends as most filings are event-driven 8-Ks, but capital allocation patterns show a clear preference for cash preservation and trust account redemptions over growth investment.

9 high priority 9 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 20, 2026

This pre-market digest covers 50 filings, with a heavy concentration of 13F-HR institutional holdings updates (12 filings) that provide a snapshot of Q2 2026 positioning but lack period-over-period comparisons. The most actionable themes center on corporate actions: Jersey Mike's Subs is moving forward with a high-profile IPO (expected price range $21-$25), while DRC Medicine's SPAC merger with Ribbon Acquisition Corp is progressing (DRC holders to own ~85.78% of the combined entity). In the energy and mining space, Gold Resource Corp is being acquired by Goldgroup Mining, with the combined entity trading under 'GORO'. Domino's Pizza reported a sharp deceleration in US same-store sales (0.1% vs 3.4% a year ago), signaling a potential consumer spending slowdown. Flex Ltd. announced a major strategic spin-off of its Cloud and Power Infrastructure segment, achieving its FY27 margin target a year early. Insider activity is limited, but a controlling stake disclosure in Margaree Acquisition Corp (75% by Mark N. Tompkins) and a significant stake increase by Korea's NPS in Shinhan Financial Group (to 9.19%) are notable. The most critical risks include a financial restatement at Adapti, Inc. and a going concern warning from Spectral Capital Corp. The overall tone is mixed, with several high-conviction corporate events offset by operational headwinds in consumer-facing sectors.

11 high priority 39 medium 50 total filings
· daily

Biotech Small-Cap Approvals — July 18, 2026

This digest covers 7 FDA approvals from July 13-14, 2026, comprising 0 NMEs, 0 biosimilars, 0 label expansions, and 7 'Other' approvals (all generic/biosimilar entries). The dominant theme is generic erosion across multiple therapeutic areas, with no single therapeutic area clustering. The highest-conviction signal is the NME approval of GEDATOLISIB (REVTORPYK) by CELCUITY INC., granted Priority Review, representing a rare bullish catalyst in an otherwise neutral period. Key risk: the absence of NME approvals outside of CELCUITY's single event signals a weak innovation cycle for small-cap biotech sponsors during this window.

7 total filings